IVZ

Invesco Reports $1,662.7B AUM for March

Invesco Ltd. (NYSE: IVZ) has announced its preliminary month-end assets under management (AUM) for March 31, 2024, amounting to $1,662.7 billion. This represents a 2.0% increase compared to the previous month-end. Notably, the firm achieved net long-term inflows of $2.8 billion during the month, with non-management fee earning net inflows at $1.8 billion and money market net outflows at $1.5 billion.

The breakdown of total AUM by asset class reveals that equity AUM increased from $871.9 billion in February 2024 to $901.9 billion in March 2024, while fixed income AUM rose from $325.1 billion to $326.8 billion over the same period. Additionally, the AUM in money market assets decreased from $194.7 billion in February 2024 to $193.2 billion in March 2024.

Looking at active AUM, the figures show an increase from $986.7 billion in February 2024 to $995.7 billion in March 2024. Within this category, equity and fixed income AUM also experienced growth, reaching $317.4 billion and $279.3 billion, respectively, in March 2024.

Conversely, passive AUM, which includes index-based ETFs, UITs, non-fee earning leverage, foreign exchange overlays, and other passive mandates, saw an increase from $644.2 billion in February 2024 to $667.0 billion in March 2024.

The overall positive performance was also influenced by favorable market returns, contributing to a $29 billion increase in AUM, partially offset by FX movements that reduced AUM by $1.1 billion. Moreover, reinvested distributions amounted to $0.9 billion.

The market has reacted to these announcements by moving the company's shares -4.0% to a price of $16.26. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS